Rights and permissions
About this article
Cite this article
Nearly one-quarter market share for hep C prescriptions held by Roche's PEG IFN-α-2a. Pharmacoecon. Outcomes News 402, 12 (2003). https://doi.org/10.1007/BF03275954
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275954